Na Lin

Title: Innovator Na Lin: Pioneering Advances in Glycosylated Protein Research

Introduction: Na Lin, an accomplished inventor based in Atlanta, GA, has made significant contributions to the field of biotechnology. His innovative research focuses on developing oligonucleotide aptamers with selective binding capabilities to glycosylated proteins. He holds a notable patent that enhances our understanding of glycosylation and its implications in various biological processes.

Latest Patents: Na Lin's prominent patent, titled "Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof," introduces a novel method for isolating oligonucleotide aptamers. These aptamers selectively bind to target glycosylated polypeptides or proteins through a boronic acid modification. This groundbreaking work not only deepens the scientific community's knowledge of glycosylation but also opens new avenues for diagnostic and therapeutic applications.

Career Highlights: Currently, Na Lin is affiliated with the Georgia State University Research Foundation, Inc., where he continues to push the boundaries of innovation in his research. His dedication to discovering new methodologies and enhancing existing techniques has established him as a prominent figure in his field.

Collaborations: Throughout his career, Na Lin has collaborated with esteemed colleagues, including Binghe Wang and Minyong Li, who have contributed their expertise to advance their collective research endeavors. Such collaborations highlight the importance of teamwork in driving innovation and achieving scientific breakthroughs.

Conclusion: Na Lin's contributions to the field of glycosylated protein research underscore the critical role of innovation in advancing biotechnology. His pioneering work in developing selective binding aptamers presents valuable possibilities for future research and applications, establishing him as a key inventor in the realm of biotechnology.